Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab After Marketing Approval in Spain

Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma

NCT03706079 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate Tezepelumab in Adults & Adolescents With Severe Uncontrolled Asthma

NCT03347279 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma

NCT03406078 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United States

NCT05329194 ·Status: COMPLETED ·Phase: PHASE4

REVErsing Airway Remodelling With Tezepelumab

NCT05651841 ·Status: RECRUITING ·Phase: PHASE3

Tezepelumab PRO Study

NCT05922891 ·Status: COMPLETED

Observational Retrospective Study on Clinical Outcomes of Patients Receiving Benralizumab in Spain.

NCT04648839 ·Status: COMPLETED

Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.

NCT06473779 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

NCT06023589 ·Status: RECRUITING ·Phase: PHASE3

TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)

NCT05729711 ·Status: ACTIVE_NOT_RECRUITING

Study to Evaluate Tezepelumab in Adults With Severe Uncontrolled Asthma

NCT03927157 ·Status: COMPLETED ·Phase: PHASE3

Tezspire Cardiac Events PASS

NCT06951867 ·Status: RECRUITING

Tezepelumab on Airway Structure and Function in Patients With Uncontrolled Moderate-to-severe Asthma

NCT05280418 ·Status: COMPLETED ·Phase: PHASE3

Estimating the Use of Resources and the Costs of Treating Patients With Asthma in the Autonomous Community of Valencia

NCT01114906 ·Status: COMPLETED

Characterisation of Patients With Severe Asthma in Primary and Secondary Care Settings in Europe Reported to be Eligible for Biological Therapy

NCT03629782 ·Status: COMPLETED

Comparative Study of the Efficacy of Biologics vs Usual Treatment on OCS Reduction for Severe Asthma Patients Using Health Insurance Claim Database

NCT05136547 ·Status: COMPLETED

Prediction of Future Risk in Patients With Controlled Asthma

NCT01565031 ·Status: UNKNOWN

Tezepelumab Treatment in Korean Severe Asthma Patients

NCT06438913 ·Status: NOT_YET_RECRUITING

Study to Characterise Patients Receiving Benralizumab in the Framework of an Individualized Access Program in Spain

NCT04126499 ·Status: COMPLETED

Study to Evaluate the Pharmacokinetics of Tezepelumab in Children With Asthma

NCT04673630 ·Status: COMPLETED ·Phase: PHASE1

One Month Dose Response Study of AZD1981 in Asthma Patients Uncontrolled on Inhaled Steroids

NCT00758589 ·Status: COMPLETED ·Phase: PHASE2

Compare the Efficacy and Safety of QL2302 Versus Tezspire® in Severe Asthma

NCT07302516 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

An Observational, Retrospective Multicentre Medical Record Review to Describe the Post-authorisation Early Clinical Experience of Dupilumab in the Treatment of Adult Severe Asthma

NCT06064526 ·Status: COMPLETED

A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma

NCT02161757 ·Status: COMPLETED ·Phase: PHASE3

Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults

NCT00385593 ·Status: TERMINATED ·Phase: PHASE3